The NPC patients in the low-risk group were usually accompanied by a higher activation of INF-γ, INF-α, KRAS, inflammatory response, apoptosis, and other related signaling pathways (Figure 6F and Table 2). This evidence concerns the gene KRAS and nasopharyngeal carcinoma.